Nuvation Bio Inc.
For the period ended Mar 31, 2026. Filed May 4, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 4, 2026
NUVB$4.20-3.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations and Comprehensive Loss
(Unaudited, in thousands, except per share data)
| For the three months ended March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| Revenue: | ||
| Product revenue, net | $18,510 | $— |
| Collaboration and license agreements revenue | 64,718 | 3,084 |
| Total revenue | 83,228 | 3,084 |
| Costs and expenses: | ||
| Cost of sales | 375 | — |
| Cost of collaboration and license agreements revenue | 5,616 | 2,094 |
| Research and development | 35,047 | 24,601 |
| Selling, general and administrative | 38,309 | 35,393 |
| Total costs and expenses | 79,347 | 62,088 |
| Income (loss) from operations | 3,881 | (59,004) |
| Other income (expense): | ||
| Interest income | 5,108 | 5,321 |
| Interest expense | (6,708) | (54) |
| Investment advisory fees | (195) | (203) |
| Change in fair value of warrant liability | 2,865 | (751) |
| Realized gain on marketable securities | 8 | 3 |
| Other income | 438 | 1,452 |
| Total other income, net | 1,516 | 5,768 |
| Income (loss) before income taxes | 5,397 | (53,236) |
| Provision for income taxes | — | — |
| Net income (loss) | $5,397 | $(53,236) |
| Basic earnings (loss) per share attributable to common stockholders | $0.02 | $(0.16) |
| Diluted earnings (loss) per share attributable to common stockholders | $0.01 | $(0.16) |
| Basic weighted average common shares outstanding | 347,332 | 338,612 |
| Diluted weighted average common shares outstanding | 377,521 | 338,612 |
| Comprehensive income (loss): | ||
| Net income (loss) | $5,397 | $(53,236) |
| Other comprehensive (loss) income, net of taxes: | ||
| Currency translation adjustment | (268) | 465 |
| Change in unrealized loss on available-for-sale securities | (1,222) | (493) |
| Comprehensive income (loss) | $3,907 | $(53,264) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.